BioMarin Pharmaceutical Inc. (FRA:BM8)
47.08
+0.02 (0.04%)
At close: Jan 30, 2026
BioMarin Pharmaceutical Employees
BioMarin Pharmaceutical had 3,040 employees as of December 31, 2024. The number of employees decreased by 361 or -10.61% compared to the previous year.
Employees
3,040
Change (1Y)
-361
Growth (1Y)
-10.61%
Revenue / Employee
€867,440
Profits / Employee
€145,905
Market Cap
9.14B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 3,040 | -361 | -10.61% |
| Dec 31, 2023 | 3,401 | 319 | 10.35% |
| Dec 31, 2022 | 3,082 | 37 | 1.22% |
| Dec 31, 2021 | 3,045 | -14 | -0.46% |
| Dec 31, 2020 | 3,059 | 58 | 1.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,356 |
| Fresenius Medical Care AG | 109,916 |
| Bayer Aktiengesellschaft | 88,502 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 62,346 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,878 |
| Carl Zeiss Meditec AG | 5,784 |
BioMarin Pharmaceutical News
- 5 days ago - BioMarin (BMRN) Secures Financing for Amicus Therapeutics Acquisition - GuruFocus
- 5 days ago - BioMarin To Raise $850 Mln In Sr. Notes To Fund Amicus Acquisition - Nasdaq
- 5 days ago - BioMarin offers $850M senior notes and syndication of a new senior secured term loan facility to fund acquisition - Seeking Alpha
- 5 days ago - BioMarin Announces Proposed Private Offering of Senior Notes and Syndication of New Senior Secured Term Loan Facility - PRNewsWire
- 11 days ago - BioMarin Pharmaceutical (BMRN) Upgraded to Buy by Canaccord Genuity | BMRN Stock News - GuruFocus
- 12 days ago - Marquette Asset Management, LLC Sells 54 Shares of BioMarin Pharmaceutical Inc (BMRN) - GuruFocus
- 15 days ago - FOLD Rises 136% in 6 Months: Should You Buy, Sell or Hold the Stock? - Nasdaq
- 16 days ago - Zacks.com featured highlights include Universal Health Services, PNC Financial Services, Global Payments and BioMarin Pharmaceutical - Nasdaq